QQ客服 官方微博 反馈留言

	Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma
	Xiaofen Li; Xia Li; Xuefeng Fang; Ying Yua
刊名	OncoTargets and Therapy
	2018
卷号	Vol.11页码:4047-4050
关键词	apatinib lung squamous cell carcinoma efficacy
ISSN号	1178-6930
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1844222
专题	四川大学
作者单位	1.Sichuan Univ, West China Hosp, Dept Abdominal Oncol, Chengdu, Sichuan, Peoples R China 2.Jie Fang Rd, Hangzhou 310009, Zhejiang, Peoples R China 3.Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, 4.Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Peoples Hosp, Dept Operat Room, Hangzhou, Peoples R China
推荐引用方式 GB/T 7714	Xiaofen Li,Xia Li,Xuefeng Fang,et al. Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma[J]. OncoTargets and Therapy,2018,Vol.11:4047-4050.
APA	Xiaofen Li,Xia Li,Xuefeng Fang,&Ying Yua.(2018).Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma.OncoTargets and Therapy,Vol.11,4047-4050.
MLA	Xiaofen Li,et al."Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma".OncoTargets and Therapy Vol.11(2018):4047-4050.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。